Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: Study protocol for a randomised controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Aawar, Nadine ^a   Alikhan, Raza ^b   Bruynseels, Daniel ^b   Cannings John, Rebecca ^a   Collis, Rachel ^b   Dick, John ^c   Elton, Christopher ^d   Fernando, Roshan ^c   Hall, Judith ^a,b   Hood, Kerry ^a   Lack, Nicki ^c   Mallaiah, Shuba ^e   Maybury, Helena ^d   Nuttall, Jacqueline ^a   Paranjothy, Shantini ^a   Rayment, Rachel ^b   Rees, Alexandra ^b   Sanders, Julia ^a,b   Townson, Julia ^a   Weeks, Andrew ^f   Collins, Peter ^a,b   more..

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

^e Liverpool Women Hospital   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Blood transfusion; Fibrinogen concentrate; Fibtem; Postpartum haemorrhage

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; SODIUM CHLORIDE; TRANEXAMIC ACID; HEMOSTATIC AGENT;

ADULT; ARTICLE; BLOOD; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CESAREAN SECTION; CONTROLLED STUDY; CRYOPRECIPITATE; DELIVERY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBTEM TEST; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOLUTIO PLACENTAE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; UTERINE ATONY; VENOUS THROMBOEMBOLISM; YOUNG ADULT; ADOLESCENT; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CLINICAL PROTOCOL; DOSE CALCULATION; DRUG ADMINISTRATION; DRUG EFFECTS; HEMOSTASIS; METHODOLOGY; PARENTERAL DRUG ADMINISTRATION; PREGNANCY; TIME FACTOR; TREATMENT OUTCOME; WALES;

ADOLESCENT; ADULT; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG DOSAGE CALCULATIONS; FEMALE; FIBRINOGEN; HEMOSTASIS; HEMOSTATICS; HUMANS; INFUSIONS, PARENTERAL; POSTPARTUM HEMORRHAGE; PREGNANCY; PROSPECTIVE STUDIES; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME; WALES; YOUNG ADULT;

EID: 84928573515     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0670-9     Document Type: Article

References (26)

1. RCOG. Royal College of Obstetricians and Gynaecologists. Prevention and Management of postpartum haemorrhage. 2011.
2. Lennox C, M.L. Scottish confidential audit of severe maternal morbidity, 9th annual report (data from 2011). Available from: http://www.scottishpatientsafetyprogramme.scot.nhs.uk/Media/Docs/MCQIC/Maternity%20Care/2013-08-09%20Final%209th%20annual%20SCASMM%20report.pdf 2013.
3. World Health Organisation. Maternal mortality: fact sheet 348. 2012; Available from: http://www.who.int/mediacentre/factsheets/fs348/en/ .
4. Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):e1-449. e7.
5. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG. 2012;119(3):306-14.
6. Mehrabadi A, Hutcheon JA, Lee L, Kramer MS, Liston RM, Joseph KS. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG. 2013;120(7):853-62.
7. Wilkinson H. Saving mothers' lives. Reviewing maternal deaths to make motherhood safer: 2006-2008. BJOG. 2011;118(11):1402-3.
8. De Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20(2):135-41.
9. Yang L, Stanworth S, Hopewell S, Doree C, Murphy M. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials (CME). Transfusion. 2012;52(8):1673-86.
10. Thomas D, Wee M, Clyburn P, Walker I, Brohi K, Collins P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010;65(11):1153-61.
11. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ, et al. Guidelines on the management of massive blood loss. Br J Haematol. 2006;135(5):634-41.
12. Stanworth SJ, Hunt BJ. The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Crit Care. 2011;15(6):1006.
13. Simon L et al. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. Br J Anaesth. 1997;78(6):678-83.
14. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266-73.
15. Gayat E, Resche-Rigon M, Morel O, Rossignol M, Mantz J, Nicolas-Robin A, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011;37(11):1816-25.
16. Cortet M, Deneux-Tharaux C, Dupont C, Collin C, Rudigoz RC, Bouvier-Colle MH, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984-9.
17. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth. 2010;19(2):218-23.
18. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med. 2008;18(3):151-7.
19. Gollop N, Chilcott J, Benton A, Rayment R, Jones J, Collis PW. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus Med. 2012;22(5):350-5.
20. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG. 2009;116(8):1097-102.
21. Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology. 2013;118(1):40-50.
22. Elashoff JD. nQuery Advisor. Version 7.0: User's Guide. Los Angeles, CA, 2007.
23. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328(7441):702-8.
24. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res. 2005;14(4):369-95.
25. Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage-an observational study. Transfus Med. 2012;22(5):344-9.
26. (RCOG) Royal College of Obstetricians and Gynaecologists. Obtaining valid consent to participate in research while in labour. Clinical governance advice. 2010.